A A A
Feed icon

News

Prof John Hardy

Prof John Hardy is the first UK winner of $3m Breakthrough Prize in Life Sciences

Professor John Hardy (UCL Institute of Neurology) has been awarded the $3 million Breakthrough Prize in Life Sciences for his pioneering research into the genetic causes of Alzheimer’s disease, other forms of dementia and Parkinson’s disease. More...

John Hardy, PhD, right, accepted the 2015 Robert A. Pritzker Prize from MJFF VP Brian Fiske, PhD, and Michael J. Fox on April 15.

John Hardy awarded 2015 Robert A. Pritzker Prize for Leadership in Parkinson's Research

One of the UK Parkinson's Disease Consortium Principal Investigators, Prof John Hardy, has been awarded the 2015 Robert A. Pritzker Prize for his leadership in Parkinson's genetics research. The award was presented by Michael J. Fox at a ceremony in New York on April 15. From the Michael J. Fox Foundation website: More...

Webcast - Prof Nicholas Wood - Advances in Genetic Understanding of Parkinson's Disease.

Video: Advances in Genetic Understanding of Parkinson's Disease

Webcast of the presentation entitled ‘Advances in Genetic Understanding of Parkinson's Disease’ given by Nicholas Wood (University College London, United Kingdom) presented at the Biochemical Society Hot Topic event, PINK1-Parkin Signalling in Parkinson’s Disease and Beyond, held in December 2014. More...

Pedigrees and I-FP-CIT SPECT scan images of the four families with GCH1 mutations involved in this study.

GCH1 gene and Parkinson's risk

A study published in Brain, led by researchers at UCL Institute of Neurology, has shown that genetic mutations which cause a decrease in dopamine production in the brain and lead to a form of childhood-onset Dystonia, also play a role in the development of Parkinson’s disease.
More...

Leonard Wolfson Experimental Neurology Centre (LWENC)

The new Leonard Wolfson Experimental Neurology Centre (LWENC) has opened for clinical studies and trials

More...

Selina Wray

(Alzheimer's Research Trust Research Fellow)

Selina Wray


I studied Biochemistry and Biological Chemistry at the University of Nottingham, where I first became interested in neurodegenerative disease after undertaking a project in Dr Rob Layfield’s laboratory, examining the role of Parkin in Parkinson’s disease. After graduating in 2004, I joined Dr Diane Hanger’s lab at the MRC Centre for Neurodegeneration Research, King’s College London, where I first became interested in the role of the microtubule protein tau in neurodegenerative disease. My PhD was awarded in 2008, and in 2009 I subsequently joined Professor John Hardy’s group in the Department of Molecular Neuroscience, where I am involved in multiple projects investigating the molecular mechanisms of frontotemporal lobar degeneration. My research continues to have a particular focus on tau-mediated neurodegeneration and I was recently awarded a research fellowship from the Alzheimer’s Research Trust to support this work. In addition to my research projects, I also coordinate a BUPA/Alzheimer’s Society funded project (led by Professor Martin Rossor) which aims to generate a biobank of familial dementia patient-derived cell lines.

esearcherID


Contact details

Page last modified on 20 mar 13 16:58